To listen to the call investors can use the following link:
http://www.arminvestorday.com/webcast
At this time it is not likely that Liz will present any market moving information it would be nice to hear about:
Treatment of first subject in Beta-Thal trial,
Treatment of first subject by City of Hope in stem cell HIV SB-728 trial,
Update on SB-728-T subjects in HAART treatment interruption,
FDA acceptance of IND for sickle cell.
No comments:
Post a Comment